BioSpace News Archive

Acute bacterial meningitis is a common, severe, neurological illness that may lead to death or neurological disabilities.

Stem cell-based therapies have increasingly become popular and are being accepted as a promising treatment for chronic disorders.

The culture media market is undergoing transformation with the launch of new products and new research studies.

Emergence of gene therapies altered the way many diseases and conditions were treated. Researchers, scientists, and experts have been developing new therapies by engineering genes and treating various conditions.

Varicose vein disorder is a commonly appeared issue among people above the age of 40.

Over the last few decades, from computers to smartphones and from single purpose to multipurpose electronic devices, technological advancements have transformed our lives in more than one way.

In successful conversations, people tend to adjust their language and talkativeness to reflect the behavior of the person they are speaking with.

Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients six years of age and older; and the maintenance treatment of airflow obstruction and reducing exacerbations for patients with chronic obstructive pulmonary disease (COPD).

TRACON Pharmaceuticals (Nasdaq: TCON), today announced financial results for the fourth quarter and year ended December 31, 2021.

Motus GI Holdings, Inc., a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced that the Company will release its fourth quarter and full year financial results on Tuesday, March 29, 2022, after the market close.